<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1625">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05140005</url>
  </required_header>
  <id_info>
    <org_study_id>AB-001-01</org_study_id>
    <nct_id>NCT05140005</nct_id>
  </id_info>
  <brief_title>GlowTest COVID-19 Antigen Home Test Kit QRI Use Study</brief_title>
  <official_title>GlowTest COVID-19 Antigen Home Test Kit Usability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arion Bio</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CSSi Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arion Bio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine the usability of the GlowTest COVID-19 Antigen&#xD;
      Home Test in a simulated home use environment. This is an open label study to evaluate the&#xD;
      usability of the GlowTest COVID-19 Antigen Home Test using information from the Quick&#xD;
      Reference Instructions and website.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the usability of the GlowTest COVID-19 Antigen Home&#xD;
      Test in Home Use. The Arion Bio GlowTest COVID-19 Antigen Home Test is a lateral flow&#xD;
      immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein&#xD;
      antigens from individuals with or without symptoms or other epidemiological reasons to&#xD;
      suspect a COVID-19 infection. The test is intended for non-prescription home use with&#xD;
      self-collected direct anterior nares swab samples from individuals ages 14 years and older or&#xD;
      adult collected anterior nares swab samples from individuals aged 2 to 13. The objective of&#xD;
      the study is to determine the usability of the GlowTest COVID-19 Antigen Home Test in a&#xD;
      simulated home use environment. This is an open label study to evaluate the usability of the&#xD;
      GlowTest COVID-19 Antigen Home Test using information from the Quick Reference Instructions&#xD;
      and website.&#xD;
&#xD;
      30 subjects (including both English speaking and Spanish speaking) will be split evenly into&#xD;
      two sections: 15 participants testing themselves and 15 participants testing another person&#xD;
      (child). There will be one testing site in the United States (US).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 8, 2021</start_date>
  <completion_date type="Anticipated">January 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 6, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>30 subjects split evenly into two sections: 15 participants testing themselves and 15 participants testing another person (child).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QRI Usability - Observer</measure>
    <time_frame>90 minutes</time_frame>
    <description>Assess the usability of the Quick Reference Instructions (QRI) based upon observer evaluation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>QRI Usability - Participant</measure>
    <time_frame>90 minutes</time_frame>
    <description>Assess the usability of the kit for home use based upon participant evaluation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Covid 19</condition>
  <arm_group>
    <arm_group_label>15 subjects testing themselves</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>15 subjects will use the Glow Test Kit to test themselves for Covid 19.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15 subjects testing someone else</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>15 subjects will use the Glow Test Kit to test someone else (a child) for Covid 19.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>GlowTest COVID-19 Antigen Home Test</intervention_name>
    <description>diagnostic testing for Covid 19</description>
    <arm_group_label>15 subjects testing someone else</arm_group_label>
    <arm_group_label>15 subjects testing themselves</arm_group_label>
    <other_name>GlowTest</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  An Institutional Review Board (IRB) approved informed consent/assent is signed and&#xD;
             dated prior to any study-related activities.&#xD;
&#xD;
          -  Males and females ages 2 and older.&#xD;
&#xD;
          -  Subject is willing to provide a self-collected nasal swab sample. (If under the age of&#xD;
             14, the sample will be collected by an adult.)&#xD;
&#xD;
          -  Subject agrees to complete all aspects of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has a visual impairment that cannot be restored with glasses or contact&#xD;
             lenses.&#xD;
&#xD;
          -  Subject has prior medical or laboratory training.&#xD;
&#xD;
          -  Subject uses home diagnostics, e.g., glucose meters, HIV tests.&#xD;
&#xD;
          -  Subject has prior experience with home COVID test kits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Geller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centennial Medical Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liwei Qi</last_name>
    <phone>4086771785</phone>
    <email>liwei@arionbio.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Decker, M.S.</last_name>
    <phone>707-494-3775</phone>
    <email>rdecker@cssienroll.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centennial Medical</name>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <zip>21075</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Steven Geller, MD</last_name>
      <phone>410-730-3399</phone>
      <email>drg@centennialmedical.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 29, 2021</study_first_submitted>
  <study_first_submitted_qc>November 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Virus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

